MENU
+Compare
MKGAF
Stock ticker: OTC
AS OF
Feb 3 closing price
Price
$142.33
Change
+$7.08 (+5.23%)
Capitalization
64.79B

MKGAF Merck KGaA Forecast, Technical & Fundamental Analysis

Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare... Show more

MKGAF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MKGAF with price predictions
Feb 03, 2026

MKGAF saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for MKGAF moved out of overbought territory on February 02, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 68 similar instances where the indicator exited the overbought zone. In of the 68 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MKGAF as a result. In of 123 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MKGAF turned negative on January 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 62 similar instances when the indicator turned negative. In of the 62 cases the stock turned lower in the days that followed. This puts the odds of success at .

MKGAF moved below its 50-day moving average on February 03, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MKGAF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MKGAF advanced for three days, in of 228 cases, the price rose further within the following month. The odds of a continued upward trend are .

MKGAF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 252 cases where MKGAF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.813) is normal, around the industry mean (29.792). P/E Ratio (17.741) is within average values for comparable stocks, (74.095). Projected Growth (PEG Ratio) (2.578) is also within normal values, averaging (2.035). Dividend Yield (0.018) settles around the average of (0.029) among similar stocks. P/S Ratio (2.466) is also within normal values, averaging (116.680).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MKGAF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MKGAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
MKGAF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

MKGAF paid dividends on April 28, 2021

Merck KGaA MKGAF Stock Dividends
А dividend of $1.40 per share was paid with a record date of April 28, 2021, and an ex-dividend date of April 26, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Frankfurter Strasse 250
Phone
+49 6151720
Employees
62908
Web
https://www.emdgroup.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONB25.400.49
+1.97%
Old National Bancorp
BWFG49.690.74
+1.51%
Bankwell Financial Group
SEDG30.970.33
+1.08%
SolarEdge Technologies
MBVIU10.34N/A
N/A
M3 Brigade Acquisition VI Corp
NTRB4.56-0.13
-2.77%
Nutriband

MKGAF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MKGAF has been loosely correlated with MKKGY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKGAF jumps, then MKKGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKGAF
1D Price
Change %
MKGAF100%
-5.63%
MKKGY - MKGAF
49%
Loosely correlated
-3.18%
AQST - MKGAF
19%
Poorly correlated
N/A
INDV - MKGAF
17%
Poorly correlated
+1.29%
EVO - MKGAF
17%
Poorly correlated
+10.82%
EBS - MKGAF
16%
Poorly correlated
-1.45%
More

Groups containing MKGAF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKGAF
1D Price
Change %
MKGAF100%
-5.63%
Pharmaceuticals: Generic
industry (214 stocks)
17%
Poorly correlated
-0.59%